Regulators delay ruling on Barr's 'morning-after pill' (Reu


Reuters - U.S. regulators have delayed a
decision on whether to approve sales of Barr Pharmaceuticals
Inc.'s "morning-after pill" Plan B without a prescription, the
company said Friday.

Read more...